Pharmaceutical Acquisition Report, 2010

Pharmaceutical M&A transaction data, statistics and valuation multiples 

Learn about the transactions that shaped today’s pharmaceutical merger and acquisition market, in the all-new Pharmaceutical Acquisition Report, First Edition, 2010. This annual report gives you vital details—including deal prices, deal terms, financial performance of acquisition targets, critical valuation figures like price/revenue and price/EBITDA multiples, and contact information for key individuals—on all publicly announced pharmaceutical mergers and acquisitions, not just the deals covered by major media.

View Abstract

Easily find essential pharmaceutical transaction data, annual pharmaceutical M&A market statistics and information. The Pharmaceutical Acquisition Report, First Edition, 2010 includes graphs and charts, rankings of largest deals and most active acquirers, as well as therapeutic areas addressed by targets. This in-depth annual review of pharmaceutical mergers and acquisitions announced during 2009 also includes an overview of the past five years of pharmaceutical M&A activity.

Order Current Edition

Get all this market intelligence and more!
●	Deal-by-deal transaction data for every announced pharmaceutical deal during 2009
●	Annual pharmaceutical M&A market activity and trend analysis
●	All the hard-to-find statistics you need to size up the market today--and tomorrow--including:     ►Price/revenue ratios     ►Price/EBITDA ratios     ►Therapeutic focus addressed by pharma targets
●	Regular Subscription $595 (PDF) Corporate Subscription $1785 (includes Excel download and unlimited distribution within                                                             your company)